Causes of Urinary Incontinence
User reported causes of Urinary Incontinence based on their intuition.
| Cause | Agree |
|---|---|
| Ataxia | 50% |
| Childbirth | 42% |
| Obesity | 33% |
| Bladder Infection | 32% |
| Peripheral Neuropathy | 31% |
| Drinking Too Much | 30% |
| Not Emptying Bladder When Voiding | 29% |
| "Holding It" for Too Long | 28% |
| Parkinson's Disease | 25% |
| Hypertension | 25% |
| Muscle Atrophy | 24% |
| Urethra Irritation (Allergies, E.g., Meds or Diet Soda) | 22% |
| Multiple Sclerosis | 21% |
| Child Abuse | 20% |
| Genetic | 17% |
| Hysterectomy | 15% |
| Spinal Cord Injury | 13% |
| Diabetes | 13% |
| Neurogenic Bladder | 10% |
| Yellow Jaundice | 10% |
| Connective Tissue Disorder (E.g., Ehlers-Danlos Syndrome) | 7% |
| Drug Side Effect | 7% |
| Hepatitis | 5% |
| Post Prostate Cancer | 3% |
| Ehrlichiosis | 0% |
Treatments
User-reported effectiveness in treating Urinary Incontinence
| Treatment | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Low Dose Naltrexone (LDN) | 0% | 33% | 0% | 67% | 0% | 3 |
| Drink Plenty of Water | 3% | 3% | 18% | 55% | 21% | 33 |
| Kegel Exercises | 0% | 23% | 5% | 68% | 5% | 22 |
| Foley Catheter | 50% | 50% | 0% | 0% | 0% | 2 |
| Diapers | 67% | 0% | 0% | 33% | 0% | 3 |
| Interstim Implant | 0% | 100% | 0% | 0% | 0% | 1 |
| Botox Injections Into Bladder | 50% | 0% | 0% | 50% | 0% | 2 |
| External Catheter | 50% | 0% | 0% | 50% | 0% | 2 |
| Intermittent Self Catheter | 33% | 33% | 0% | 33% | 0% | 3 |
| Sanctura | 0% | 50% | 0% | 50% | 0% | 2 |
| Ditropan XL | 0% | 33% | 0% | 67% | 0% | 3 |
| Accupuncture | 0% | 60% | 20% | 20% | 0% | 5 |
| Sanctura XR | 0% | 0% | 0% | 100% | 0% | 2 |
| Ditropan | 0% | 0% | 0% | 100% | 0% | 4 |
| Cranberry | 0% | 7% | 7% | 79% | 7% | 14 |
| Oxybutynin Patch | 0% | 20% | 20% | 60% | 0% | 5 |
| Vesicare | 0% | 25% | 25% | 50% | 0% | 4 |
| Detrol | 0% | 22% | 22% | 33% | 22% | 9 |
Treatments Causing Urinary Incontinence
User-reported treatments that exhibited the side effect of Urinary Incontinence
| Treatment | Percent of Reports |
|---|---|
| Leuprolide | 17% |
Outcomes
Below is the degree of change seen after Urinary Incontinence is higher than average.
|
|
Predictors
Below is the change in Urinary Incontinence seen after the predictor is higher than average.
|
|
Outcomes Label
Predictors Label
Urinary Incontinence Info
| Property | Value |
|---|---|
| Variable Name | Urinary Incontinence |
| Aggregation Method | MEAN |
| Analysis Performed At | 2020-03-02 |
| Duration of Action | 24 hours |
| Maximum Allowed Value | 5 out of 5 |
| Minimum Allowed Value | 1 out of 5 |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 0 seconds |
| Unit | 1 to 5 Rating |
| User Variables | 0 |
| Variable Category | Symptoms |
| Variable ID | 86919 |